Project Grant HT94252410985
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...
The University of Texas Southwestern Medical Center received a $246,000 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program to support research probing a new risk cell type to treat multiple sclerosis. The two-year award beginning September 1, 2021 will fund research investigating medical solutions for multiple sclerosis through the support of basic, applied, and advanced biomedical research. The place of performance for the...
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
This federal Project Grant award of $320,000.00 from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "MULTIPLE SCLEROSIS DISPARITIES: EVALUATION OF CHRONIC STRESS LOAD AND SOCIAL FACTORS". The award, effective September 30, 2024 through September 29, 2026, has been transferred from Johns Hopkins University to The Washington University in St. Louis. The project aims to advance research on...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
This federal Project Grant award, titled "POLYGENICITY OF BRAIN AND PHYSICAL RESERVE IN MULTIPLE SCLEROSIS", is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $249,823 award, which commenced on September 1, 2025 and is scheduled for completion on August 31, 2027, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant recipient,...